Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

FDA Approves Dako Omnis Test to Guide Colorectal Cancer Treatment

Summary by curetoday.com
The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.

2 Articles

TagesschauTagesschau
Center

Only a Few Insured People Use Cancer Test for Prevention

Colon cancer is one of the most common causes of cancer-related death. However, only a few insured persons use a stool test for early detection according to an evaluation of the Barmer health insurance.[more]]>

·Hamburg, Germany
Read Full Article
curetoday.comcuretoday.com

FDA Approves Dako Omnis Test to Guide Colorectal Cancer Treatment

The FDA approved the Dako Omnis panel to identify patients with colorectal cancer with mismatch repair deficiency.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

curetoday.com broke the news in on Thursday, August 21, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Cancer icon

Cancer

United States icon

United States

Germany icon

Germany

News
For You
SearchBlindspotLocal